SUPRAX
These highlights do not include all the information needed to use SUPRAX® safely and effectively. See full prescribing information for SUPRAX®. SUPRAX® (cefixime) tablets, for oral useSUPRAX® (cefixime) capsules, for oral useSUPRAX® (cefixime) chewable tablets, for oral useSUPRAX® (cefixime) for oral suspension Initial U.S. Approval: 1986
d0fd45bd-7d52-4fa6-a5f7-f46d5651ffa2
HUMAN PRESCRIPTION DRUG LABEL
Dec 15, 2023
Lupin Pharmaceuticals, Inc.
DUNS: 089153071
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
cefixime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
cefixime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
cefixime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
cefixime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
cefixime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
cefixime
Product Details
FDA regulatory identification and product classification information